The Food and Drug Administration issued a warning in June 2011 that diabetic patients who have taken Actos and other pioglitazone-containing medicines are at a higher risk of developing bladder cancer. The warning notes that the risk is higher in patients who have taken higher dosages of Actos for more than 12 months.
France has stopped the release of these drugs. The FDA noted that it was aware of France’s decision. However, the FDA has not banned these medicines from being issued in the United States.
Gersowitz Libo & Korek, P.C. has been researching patients who have developed bladder cancer as a result of taking Actos and is now accepting new clients. If you or a loved one has fallen victim to the drug Actos, contact Gersowitz Libo & Korek, P.C. at (800) 529-9997 to learn your legal rights.
Elderly Driver Involved in Howell Car Accident at Nail Pro Salon on Route 9 South…
Investigation Underway After Pedestrian Died in Union Collision on Route 495 UNION, NEW JERSEY (December…
Investigation Underway After Woman Died in Collision Involving MTA Train in Manhattan by West 44th…
Panama Central School District Bus Involved in Fatal Jamestown School Bus Collision With 4-Year-Old Girl…
NYPD Searching for Driver Involved In Fatal East Harlem Collision near East 118th Street and…
First Responders Rescued Construction Worker After He Fell Through Manhole Cover in Washington Heights WASHINGTON…